14-day Premium Trial Subscription Try For FreeTry Free
$0.0008
+0 (+0%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days $0.0007 $0.0023 Friday, 3rd May 2024 PPCB stock ended at $0.0008. During the day the stock fluctuated 14.29% from a day low at $0.0007 to a day high of $0.0008.
90 days $0.0007 $0.0065
52 weeks $0.0001 $0.263

Historical Propanc Biopharma Inc prices

Date Open High Low Close Volume
Aug 23, 2023 $0.0338 $0.0400 $0.0325 $0.0350 343 171
Aug 22, 2023 $0.0390 $0.0397 $0.0256 $0.0300 297 457
Aug 21, 2023 $0.0470 $0.0470 $0.0375 $0.0400 342 352
Aug 18, 2023 $0.0450 $0.0500 $0.0416 $0.0475 202 609
Aug 17, 2023 $0.0475 $0.0529 $0.0475 $0.0480 91 440
Aug 16, 2023 $0.0500 $0.0529 $0.0405 $0.0529 309 972
Aug 15, 2023 $0.0501 $0.0530 $0.0450 $0.0480 198 514
Aug 14, 2023 $0.0600 $0.0600 $0.0500 $0.0501 137 630
Aug 11, 2023 $0.0611 $0.0611 $0.0500 $0.0579 148 999
Aug 10, 2023 $0.0560 $0.0700 $0.0538 $0.0660 237 219
Aug 09, 2023 $0.0506 $0.0565 $0.0500 $0.0550 89 288
Aug 08, 2023 $0.0551 $0.0551 $0.0500 $0.0540 220 949
Aug 07, 2023 $0.0694 $0.0700 $0.0551 $0.0559 312 345
Aug 04, 2023 $0.0700 $0.0700 $0.0586 $0.0601 286 620
Aug 03, 2023 $0.0671 $0.0750 $0.0640 $0.0703 298 653
Aug 02, 2023 $0.0722 $0.0749 $0.0650 $0.0689 581 193
Aug 01, 2023 $0.0720 $0.0798 $0.0720 $0.0754 107 616
Jul 31, 2023 $0.0900 $0.0900 $0.0731 $0.0731 190 983
Jul 28, 2023 $0.0850 $0.0865 $0.0727 $0.0800 569 914
Jul 27, 2023 $0.0850 $0.0885 $0.0763 $0.0835 540 827
Jul 26, 2023 $0.0920 $0.0920 $0.0810 $0.0879 433 866
Jul 25, 2023 $0.110 $0.110 $0.0895 $0.0920 331 590
Jul 24, 2023 $0.110 $0.110 $0.0845 $0.109 682 489
Jul 21, 2023 $0.109 $0.119 $0.0920 $0.110 317 187
Jul 20, 2023 $0.122 $0.122 $0.101 $0.109 401 533
Click to get the best stock tips daily for free!

About Propanc Biopharma Inc

Propanc Biopharma Propanc Biopharma, Inc., a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. The company has a research collaboration with University of Jaén to commence the POP1 joint drug disc... PPCB Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT